Skip to McMaster Navigation Skip to Site Navigation Skip to main content
McMaster logo

Faculty of Health Sciences

The Science of Addiction and Mental health Advancing Actionable knowledge Now (SAMAAN)

POST

PHARMACOGENETICS OF OPIOID SUBSTITUTION TREATMENT RESPONSE (POST) STUDY

The POST study aims to determine how treatment response differs based on genetic differences. Participants are recruited from opioid addiction treatment centres in Ontario, Canada. Further, the role of cannabis in treatment outcomes is explored through phenotypic data and biological samples.

Publications from the POST Study

WEBSITE

A genome-wide association, polygenic risk score and sex study on opioid use disorder treatment outcomes.

Alannah McEvoy

WEBSITE

Are patients’ goals in treatment associated with expected treatment outcomes? Findings from a mixed-methods study on outpatient pharmacological treatment for opioid use disorder

Tea Rosic

WEBSITE

Assessing fragility of statistically significant findings from randomized controlled trials assessing pharmacological therapies for opioid use disorders: a systematic review

Leen Naji

WEBSITE

Cannabis use and opioid relapse: An exploratory survival analysis of prospectively collected data

Leen Naji

WEBSITE

Cannabis use in patients treated for opioid use disorder pre- and post-recreational cannabis legalization in Canada

Tea Rosic

WEBSITE

Exploring psychological symptoms and associated factors in patients receiving medication-assisted treatment for opioid-use disorder

Tea Rosic

WEBSITE

Factors Associated With Increased Opioid Use During the COVID-19 Pandemic: A Prospective Study of Patients Enrolled in Opioid Agonist Treatment

Tea Rosic

WEBSITE

Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk?

Vivian Y O Au

WEBSITE

Genetics of cannabis use in opioid use disorder: A genome-wide association and polygenic risk score study

Alannah Hillmer

WEBSITE

Health service utilization, substance use treatment response, and death in patients with opioid use disorder and comorbid hepatitis C findings from prospective cohort study with administrative database linkage

Brittany Dennis

WEBSITE

Patient-Reported Goals of Youths in Canada Receiving Medication-Assisted Treatment for Opioid Use Disorder

Darren Chai

WEBSITE

Sensitivity and specificity of self-reported psychiatric diagnoses amongst patients treated for opioid use disorder

Kelly Leung

WEBSITE

Sex-Specific Risk Factors and Health Disparity Among Hepatitis C Positive Patients Receiving Pharmacotherapy for Opioid Use Disorder: Findings From a Propensity Matched Analysis

Brittany Dennis

WEBSITE

Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder

Emma van Reekum

WEBSITE

The association between cannabis use and outcome in pharmacological treatment for opioid use disorder

Tea Rosic

WEBSITE

The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort study

Brittany Dennis

WEBSITE

The Inclusion of Patients’ Reported Outcomes to Inform Treatment Effectiveness Measures in Opioid Use Disorder. A Systematic Review

Nitika Sanger

WEBSITE

The Role of Cannabis Use in Suicidal Ideation Among Patients With Opioid Use Disorder

Leen Naji

WEBSITE

Treatment Outcomes in Patients With Opioid Use Disorder Who Were First Introduced to Opioids by Prescription: A Systematic Review and Meta-Analysis

Nitika Sanger